Entera Bio ENTX Income Statement (2017-2026)

NASDAQ ENTX
$3.29 +0.07 (+2.17%)
As of: Aug 21, 2026 · 12:37 PM EDT
Income Statement Dec2017 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
0.14M0.17M0.07M0.04M0.01M0.01M0.06M0.04M0.08M0.04M
Cost of Revenue (Quarter)
0.07M0.14M0.05M0.03M0.01M0.01M0.05M0.04M0.08M0.04M
Gross Profit (Quarter)
0.07M0.03M0.01M0.01M0.00M0.01M0.01M
Operating items
Research & Development (Quarter)
1.77M2.65M1.69M1.39M1.41M1.35M0.93M1.21M1.37M1.00M0.73M1.09M1.48M1.20M1.12M1.52M1.64M1.72M2.25M3.20M
Selling, General & Administrative (Quarter)
1.53M1.48M2.17M1.88M1.46M1.74M1.29M1.14M1.03M0.97M1.33M1.09M1.54M1.14M1.44M1.15M1.61M1.32M1.29M1.36M
Other Operating Expenses (Quarter)
0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.01M
Operating Expenses (Quarter)
3.29M4.12M3.85M3.26M2.87M3.07M2.21M2.33M2.39M1.96M2.06M2.17M3.02M2.34M2.56M2.67M3.26M3.04M3.54M4.56M
Operating Income (Quarter)
-3.22M-4.09M-3.83M-3.25M-2.87M-3.07M-2.21M-2.33M-2.39M-1.96M-2.06M-2.20M-3.02M-2.34M-2.56M-2.70M-3.30M-3.03M-3.54M-4.56M
EBIT (Quarter)
-3.22M-4.09M-3.83M-3.25M-2.87M-3.07M-2.21M-2.33M-2.39M-1.96M-2.06M-2.20M-3.02M-2.34M-2.56M-2.70M-3.30M-3.03M-3.54M-4.56M
Non-operating items
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)
-0.01M-0.03M0.04M0.06M-0.01M-0.01M0.02M0.01M0.04M-0.03M0.04M0.02M-0.01M-0.00M0.01M0.06M0.03M0.03M-2.75M
Net income details
EBT (Quarter)
-3.23M-4.12M-3.79M-3.19M-2.87M-3.08M-2.19M-2.33M-2.35M-2.00M-2.06M-2.44M-3.02M-2.34M-2.62M-2.73M-3.43M-3.14M-3.61M-4.58M
Tax Provisions (Quarter)
-0.01M-0.01M-0.01M-0.00M0.19M-0.05M0.03M0.01M
Profit After Tax (Quarter)
-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.02M-2.15M-3.02M-2.36M-2.57M-2.66M-3.20M-3.02M-3.50M-7.31M
Income from Continuing Operations (Quarter)
-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.06M-2.44M-3.02M-2.36M-2.62M-2.73M-3.43M-3.14M-3.61M-4.58M
Consolidated Net Income (Quarter)
-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.06M-2.44M-3.02M-2.36M-2.62M-2.73M-3.43M-3.14M-3.61M-4.58M
Income towards Parent Company (Quarter)
-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.06M-2.44M-3.02M-2.36M-2.62M-2.73M-3.43M-3.14M-3.61M-4.58M
Net Income towards Common Stockholders (Quarter)
-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.06M-2.44M-3.02M-2.36M-2.62M-2.73M-3.43M-3.14M-3.61M-4.58M
Additional items
EPS (Basic) (Quarter)
-0.11-0.16-0.13-0.11-0.11-0.11-0.08-0.08-0.08-0.07-0.06-0.07-0.08-0.06-0.06-0.06-0.07-0.07-0.08-0.09
EPS (Diluted) (Quarter)
-0.11-0.16-0.13-0.11-0.11-0.11-0.08-0.08-0.08-0.07-0.06-0.07-0.08-0.06-0.06-0.06-0.07-0.07-0.08-0.09
Shares Outstanding (Quarter)
28.68M26.13M28.80M28.81M28.81M28.81M28.81M28.81M28.81M29.01M36.74M37.09M37.64M37.65M43.38M46.84M47.09M46.19M47.76M50.45M
Shares Outstanding (Diluted) (Quarter)
28.68M26.13M28.80M28.81M28.81M28.81M28.81M28.81M28.81M29.01M36.74M37.09M37.64M37.65M43.38M46.84M47.09M46.19M47.76M50.45M
Shares Outstanding (Entity) (Quarter)
28.78M28.80M28.80M28.81M28.81M28.81M28.81M28.81M28.81M29.01M35.53M36.31M36.51M38.84M45.42M45.45M45.66M46.18M46.62M49.29M
EBITDA (Quarter)
-3.22M-4.09M-3.83M-3.25M-2.87M-3.07M-2.21M-2.33M-2.39M-1.96M-2.06M-2.20M-3.02M-2.34M-2.56M-2.70M-3.30M-3.03M-3.54M-4.56M
Interest Expenses (Quarter)
15.03M17.64M0.54M0.48M19.47M0.23M0.03M0.12M0.06M0.03M0.13M0.11M0.07M0.02M
Tax Rate (Quarter)
0.40%0.36%0.18%0.13%-6.75%1.49%-1.23%-0.60%